<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01823432</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-11-0185</org_study_id>
    <nct_id>NCT01823432</nct_id>
  </id_info>
  <brief_title>Genetic Risks for Bicuspid Aortic Valve Disease</brief_title>
  <official_title>Genetic Risks for Bicuspid Aortic Valve Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but&#xD;
      very little is known about the genetic causes or risk factors for adverse outcomes.&#xD;
      Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years&#xD;
      old are caused by BAVs. BAV patients are also at high risk to develop aneurysms of the&#xD;
      ascending aorta, which may lead to aortic dissections. Dr. Prakash and his colleagues plan to&#xD;
      use individual genetic information to identify persons with BAV who are at high risk for&#xD;
      complications and to customize therapies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To be included in the study, patients must have a bicuspid or unicuspid aortic valve,&#xD;
      documented by clinical history or imaging studies. If the aortic valve was replaced&#xD;
      surgically, they may still be eligible. Participants will be asked to donate a single tube of&#xD;
      blood and fill out a questionnaire. Patients will also be followed up by telephone or email&#xD;
      about once a year to determine if they experience any medical complications related to&#xD;
      Bicuspid Aortic Valve (BAV), such as aortic aneurysms, aortic dissections or valve disease.&#xD;
      Patients may not be included if they are less than 18 years old at the time of recruitment or&#xD;
      have a recognized genetic syndrome or genetic mutation such as Marfan or Ehlers-Danlos&#xD;
      syndrome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Thoracic aortic aneurysms and dissections</measure>
    <time_frame>10 years</time_frame>
    <description>Development of new aneurysms and/or dissections of the thoracic aorta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aortic valve replacement surgery</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aortic enlargement</measure>
    <time_frame>10 years</time_frame>
    <description>Dilation of thoracic aorta, new or progressive</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Aortic valve degeneration</measure>
    <time_frame>10 years</time_frame>
    <description>Increase in valve degeneration score by at least 1 unit</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Bicuspid Aortic Valve</condition>
  <condition>Unicuspid Aortic Valve</condition>
  <arm_group>
    <arm_group_label>BAV Cohort</arm_group_label>
    <description>Patients with bicuspid or unicuspid aortic valves, regardless of surgical status.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Genomic DNA from whole blood Genomic DNA from saliva Aortic valve tissue preserved in&#xD;
      RNALater&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults at least 18 years old with unicuspid or bicuspid aortic valves&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  Diagnosis of bicuspid or unicuspid aortic valve&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 18 years of age&#xD;
&#xD;
          -  Recognized syndrome or identified genetic mutation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siddharth Prakash, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Siddharth Prakash, MD, PhD</last_name>
    <phone>713-500-7003</phone>
    <email>Siddharth.K.Prakash@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Texas Health Science Center Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Jennings</last_name>
      <email>MSBicuspidAorticValveStudy@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <phone>713-500-6704</phone>
    </contact_backup>
    <investigator>
      <last_name>Siddharth Prakash, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dianna Milewicz, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.johnritterresearchprogram.org/</url>
    <description>John Ritter Research Program in Aortic and Vascular Disease</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Siddharth Prakash</investigator_full_name>
    <investigator_title>Assistant Professor - Internal Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
    <mesh_term>Bicuspid Aortic Valve Disease</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

